-
Bristol Myers Squibb Reports Second Quarter 2020 Financial Results
Post on 8/6/20
-
Provention Bio Reports Second Quarter 2020 Financial Results and Provides Business Update
Post on 8/6/20
-
Amneal Reports Second Quarter 2020 Financial Results
Post on 8/6/20
-
Concord Health Partners Announces Investment in Cedar's Series C Funding
Post on 8/6/20
-
Pacira BioSciences Reports Second Quarter 2020 Financial Results and Business Update
Post on 8/6/20
-
BioLineRx Reports Second Quarter 2020 Financial Results and Provides Corporate Update
Post on 8/6/20
-
MeiraGTx Reports Second Quarter 2020 Financial Results
Post on 8/6/20
-
CipherHealth Accelerates Growth with Financing from CIBC Innovation Banking
Post on 8/6/20
-
22nd Century Group Reports Financial Results and Business Highlights for the Second Quarter 2020
Post on 8/6/20
-
Teladoc Health Merging with Livongo Health in Deal Worth $18.5 Billion
Post on 8/6/20
-
OPEN MINDS & NextGen Healthcare Form Platinum Partnership
Post on 8/5/20
-
Citius Pharmaceuticals Announces $6M Bought Deal Offering
Post on 8/5/20
-
Immunic Announces Pricing of $90.0 Million Public Offering of Common Stock
Post on 8/5/20
-
Genesis Biotechnology Group Acquires Comparative Biosciences
Post on 8/5/20
-
Regeneron Reports Second Quarter 2020 Financial and Operating Results
Post on 8/5/20
-
Oyster Point Pharma Reports Second Quarter 2020 Financial Results and Recent Business Highlights
Post on 8/5/20
-
Teladoc Health and Livongo Merge
Post on 8/5/20
-
Merck Animal Health Completes Acquisition of IdentiGEN
Post on 8/5/20
-
Will Moderna Get Away With Charging 50% More Than Pfizer for Its Coronavirus Vaccine?
Post on 8/5/20
-
Merck and Hanmi Pharmaceutical Enter into Licensing Agreement
Post on 8/4/20
-
Ivy Rehab Joins UnitedHealthcare and Oxford Health Plans as In-Network Provider in New York
Post on 8/4/20
-
Quartet Health Partners With SilverCloud Health
Post on 8/4/20
-
Cytovia Therapeutics Acquires Worldwide Rights to CytoImmune Therapeutics
Post on 8/4/20
-
RespireRx Pharmaceuticals Announces $2 Million Funding Commitment
Post on 8/4/20
-
Arvinas Reports Second Quarter 2020 Financial Results and Provides Corporate Update
Post on 8/4/20
New York
